abstract |
The present invention relates to the specific substituted heterocyclic fused γ carboline compounds of free form as described herein, solid form, pharmaceutically acceptable salt form and/or substantially pure form, their prodrug, its pharmaceutical composition and method for treating disease, the disease is related to:5 HT2A acceptors, serotonin transporter (SERT) and/or the approach for being related to d2 dopamine receptor signal transducting system. |